RAYMOND Group's Restructuring to Re-FOCUS on its Core Businesses
M & A Critique|June 2023
For the last couple of years, it appears Raymond Limited has relentlessly been trying to simplify its structure & create value for shareholders.
Anirudha Jain
RAYMOND Group's Restructuring to Re-FOCUS on its Core Businesses

The group announced a couple of internal restructurings by calling a step towards creating value for its shareholders. Some of them were withdrew after announcements. In yet another similar move, Raymond Limited announced internal restructuring to list its apparel business separately But this time they also announced selling of their identified Fast-Moving Consumer Goods (FMCG) business to deleverage its balance sheet.

Raymond Limited ("RL" or "Demerged Company") is a leading Indian textile, lifestyle, and branded apparel company with a wide network of operations in local as well foreign markets. RL is also engaged in the development of residential commercial real estate projects. The equity shares of RL are listed on the nationwide bourses. The Non-Convertible Debentures of RL are listed on the Negotiated Trade Reporting Platform of NSE.

Raymond Consumer Care Limited ("RCCL" or "Resulting Company" or "Transferee Company") is engaged primarily in the business of manufacture and sale of condoms and marketing of fastmoving consumer goods. RCCL is a wholly owned subsidiary of Ray Global Consumer Trading Limited.

Ray Global Consumer Trading Limited ("RG" or "Transferor Company") is primarily engaged in the business of investment in shares. RL holds 47.66% of the paid-up equity share capital of RG. Of the remaining 52.34%, 49.68% stake is held by Promoters of RL & 2.65% by other shareholders.

Godrej Consumer Products Limited ("GCPL") is a part of the Godrej group engaged in FMCG business. The equity shares of GCPL are listed on nationwide bourses.

The Transaction

Slump Sale of FMCG Business:

Before the current transaction, Raymond group in 2018 consolidated its entire FMCG business under a single entity through a composite scheme of arrangement.

Bu hikaye M & A Critique dergisinin June 2023 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

Bu hikaye M & A Critique dergisinin June 2023 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

M & A CRITIQUE DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Batliboi Ltd. merging its associate company
M & A Critique

Batliboi Ltd. merging its associate company

Batliboi Limited has a history of collaborations with various foreign technical partners and has subsidiaries like Hydraulic & General Engineers Ltd. and Batliboi International Ltd. In March 2024, the board of Directors of Batliboi Limited accorded their approval for the merger of promoter owned private company with itself.

time-read
2 dak  |
May 2024
TVS Motors issuances of convertible preference shares as bonus instead of dividend
M & A Critique

TVS Motors issuances of convertible preference shares as bonus instead of dividend

Recently, well known auto manufacturer announced the issuance of preference shares as a bonus to all equity shareholders.

time-read
3 dak  |
May 2024
Aditya Birla Fashion & Retails Scheme to undo its consolidation
M & A Critique

Aditya Birla Fashion & Retails Scheme to undo its consolidation

Corporate restructuring saga continues for Aditya Birla Group.

time-read
5 dak  |
May 2024
Advent International to combine its listed & private entity business
M & A Critique

Advent International to combine its listed & private entity business

Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company.

time-read
6 dak  |
April 2024
Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio
M & A Critique

Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio

Recently, Eris Lifesciences Limited announced acquisition of 'branded Formulation Business' of Biocon Biologics Limited pertaining to the India territory through slump sale. In addition, ELL also announced a foreign acquisition.

time-read
7 dak  |
April 2024
Vuenow Merges All Entities Will It Create Value?
M & A Critique

Vuenow Merges All Entities Will It Create Value?

Recently, Vuenow Infratech Limited, a BSE listed company, announced the merger of two private companies itself.

time-read
6 dak  |
April 2024
Dalmia Group continues its journey of segregation of businesses by way of demerger
M & A Critique

Dalmia Group continues its journey of segregation of businesses by way of demerger

Recently Dalmia Group announced yet another restructuring of one of its group companies Dalmia Bharat Refractories Limited.

time-read
6 dak  |
March 2024
Rane Group to consolidate its listed operational entities
M & A Critique

Rane Group to consolidate its listed operational entities

After keeping different operational listed entities for years, Rane Group, one of the key players in Auto Ancillary space has decided to consolidate its listed operational companies under Rane (Madras) Limited.

time-read
3 dak  |
March 2024
Zuari Group's attempts to create the biggest private producer of Fertilisers
M & A Critique

Zuari Group's attempts to create the biggest private producer of Fertilisers

“Transfer of Identified shares from ZACL to ZMPPL is a precondition for approval of the merger transaction”

time-read
7 dak  |
March 2024
Shankara Building Products separates its trading & marketplace business for independent growth
M & A Critique

Shankara Building Products separates its trading & marketplace business for independent growth

Recently, Shankara Building Products Limited announced the demerger of its trading/building material marketplace business from its manufacturing business.

time-read
4 dak  |
February 2024